Phase 2 Nephrotoxicity Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity
NephrotoxicityCisplatin Nephrotoxicity
Minia University50 enrolled1 locationNCT07564479
Recruiting
Phase 2
Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
Solid TumorsCisplatin Nephrotoxicity
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran46 enrolled1 locationNCT07018622
Recruiting
Phase 2
L-Carnitine Protective Effect in Nephrotoxicity
Nephrotoxicity
Tanta University46 enrolled1 locationNCT07108777
Recruiting
Phase 2
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
NephrotoxicityMucositisOtotoxicity
Matrix Biomed, Inc.120 enrolled9 locationsNCT03480971